Regulations for the Manufacture and Control of Live Poliovirus Vaccine: International Experience and China's Path / 中国医学科学杂志(英文版)
Chinese Medical Sciences Journal
;
(4): 315-320, 2023.
Article
Dans Anglais
| WPRIM
| ID: wpr-1008998
ABSTRACT
The eradication of poliomyelitis is a landmark achievement in the history of public health, providing strong protection for children's health. The introduction of the Chinese Regulations for the Manufacture and Control of Live Poliovirus Vaccine is a prerequisite and safeguard for the large-scale production and use of domestically produced live poliovirus vaccines, serving as an indispensable component of vaccine safety. This article, based on archival documents, letters, collections of essays, and oral interviews, examines the historical experience of the development of Chinese Regulations for the Manufacture and Control of Live Poliovirus Vaccine. It contends that the emphasis on localization and the active engagement in international cooperation are critical factors in the swift introduction of Chinese Regulations for the Manufacture and Control of Live Poliovirus Vaccine.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Poliomyélite
/
Vaccin antipoliomyélitique inactivé
/
Chine
/
Épidémies de maladies
Limites du sujet:
Enfant
/
Humains
Pays comme sujet:
Asie
langue:
Anglais
Texte intégral:
Chinese Medical Sciences Journal
Année:
2023
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS